162 related articles for article (PubMed ID: 4203986)
1. [On the sensitivity to TUM-N of tubercle bacilli isolated from tuberculous patients who had never employed TUM-N--for determination of the critical concentration of TUM-N resistance (author's transl)].
Toyoara M
Kekkaku; 1973 Sep; 48(9):405-10. PubMed ID: 4203986
[No Abstract] [Full Text] [Related]
2. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
Saito T; Fukuhara Y
Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
[No Abstract] [Full Text] [Related]
3. [The effects of antituberculous chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli (author's transl)].
Uratsuji Y
Bull Chest Dis Res Inst Kyoto Univ; 1978 Mar; 10(1-2):20-9. PubMed ID: 99201
[No Abstract] [Full Text] [Related]
4. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
Saito T; Fukuhara Y
Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
[No Abstract] [Full Text] [Related]
5. [Possibilities of advances in the determination of drug resistance of tubercle bacilli].
Buraczewska M
Gruzlica; 1971 Aug; 39(8):729-37. PubMed ID: 4999630
[No Abstract] [Full Text] [Related]
6. [A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)].
Tsukamura M
Kekkaku; 1978 Oct; 53(10):495-8. PubMed ID: 102861
[No Abstract] [Full Text] [Related]
7. Sensitivity to ethambutol and to capreomycin in wild strains of Tubercle bacilli isolated from patients previously untreated with these drugs.
Blitek-Golc D; Zduńczyk-Pawelek H; Antosiewicz A
Pol Med J; 1971; 10(4):945-51. PubMed ID: 5001656
[No Abstract] [Full Text] [Related]
8. [Drug activity of bleomycin against tubercle bacilli isolated from pulmonary tuberculous in-patients (author's transl)].
Endo K
Jpn J Antibiot; 1973 Dec; 26(6):501-3. PubMed ID: 4131340
[No Abstract] [Full Text] [Related]
9. [Antitubercular effect of capreomycin in vitro].
Janowiec M
Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
[No Abstract] [Full Text] [Related]
10. [Determination of drug sensitivity of Mycobacterium tuberculosis by means of potassium tellurite].
Kovalev GK
Antibiotiki; 1969 Apr; 14(4):323-5. PubMed ID: 4977639
[No Abstract] [Full Text] [Related]
11. Study on tuberactinomycin-N. I. In vitro Antibacterial activity of TUM-N on Tubercle bacilli isolated from patients.
Shimizu T
Jpn J Antibiot; 1974 Aug; 27(4):463-70. PubMed ID: 4140247
[No Abstract] [Full Text] [Related]
12. [Bacteriostatic effect of ethambutol on tubercle bacilli sensitive or resistant to other antitubercular drugs. A modification of the vertical diffusion method for determination of biologically active ethambutol].
Strupczewska-Januszowa H; Grzymska L; Zwolińska G
Gruzlica; 1969 Jul; 37(7):623-8. PubMed ID: 4981782
[No Abstract] [Full Text] [Related]
13. A comparative study of the susceptibility to major and minor drugs of tubercle bacilli isolated from 100 consecutive patients never treated with minor drugs.
Tan THIAM HOK ; The KIE SENG ; Yang SHE YEN ; Tan LIOE SAN
Paediatr Indones; 1966; 6(2):71-4. PubMed ID: 4960067
[No Abstract] [Full Text] [Related]
14. [Clinical study on tuberactinomycin-N (TUM-N) and viomycin (VM) in retreatment of pulmonary tuberculosis (author's transl)].
Kekkaku; 1974 Jul; 49(7):207-15. PubMed ID: 4372439
[No Abstract] [Full Text] [Related]
15. [Experimental studies in vitro on the antituberculous activities of tuberactinomycin (TUM) and tuberactinomycin-N (TUM-N) (author's transl)].
Maekawa N; Ikeda N; Oda Y; Uratsuji Y; Inagake H
Kekkaku; 1977 May; 52(5):211-8. PubMed ID: 407391
[No Abstract] [Full Text] [Related]
16. [Secondary drug sensitivity of tubercle bacilli in chronic sputum-positive tuberculosis patients].
Telejko Z
Gruzlica; 1970 Oct; 38(11):1101-4. PubMed ID: 4992233
[No Abstract] [Full Text] [Related]
17. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
Tsukamura M; Mizuno S; Yamamoto M
Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
[No Abstract] [Full Text] [Related]
18. [Epidemiology of primary drug resistance in tuberculosis in the Federal Republic of Germany including Berlin (West) during 1972 to 1975 (author's transl)].
Matthiessen W; Kind A; Göbel D
Prax Klin Pneumol; 1977 Oct; 31(10):890-8. PubMed ID: 412177
[No Abstract] [Full Text] [Related]
19. Studies on cross-resistance between isoniazid, isoxyl, teebazone, ethionamide and ethambutol of tubercle bacilli from patients never treated with those drugs except with isoniazid.
Tan TH; The KS; Yang SY; Tan LS; Ko HL; Tjie HB; Chatim A
Paediatr Indones; 1966; 6(1):32-8. PubMed ID: 4959380
[No Abstract] [Full Text] [Related]
20. [Observations on the chemo-antibiotic-resistance in vitro of more than 400 strains of Mycobacterium tuberculosis recently isolated].
Spaziante G; Caroli G; Mazzarone R
Riv Ital Ig; 1966; 26(5):512-34. PubMed ID: 4967921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
